None
Quote | HypGen Inc (OTCMKTS:HPGN)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $1.00 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 02/12/2020 04:36:00 pm |
News | HypGen Inc (OTCMKTS:HPGN)
CENTURY CITY, CA , Jan. 05, 2018 (GLOBE NEWSWIRE) -- HypGen Inc. (OTCQB: HPGN), announced it will present during the Biotech Showcase™ 2018, in San Francisco. HypGen is developing the drug RP-323 for the treatment of Parkinson's disease. HypGen’s CEO, Dr. McCoy L. More...
Message Board Posts | HypGen Inc (OTCMKTS:HPGN)
Subject | By | Source | When |
---|---|---|---|
HPGN registration revoked: | Renee | investorshub | 06/28/2021 1:45:17 PM |
$RCHA will be the next one to | elkonig | investorshub | 07/07/2020 3:22:45 PM |
HPGN SEC Suspension for severely delinquent Financials: | Renee | investorshub | 07/07/2020 1:38:21 PM |
Crazy quit here! | beer$$money | investorshub | 03/26/2018 4:09:42 PM |
$HPGN News is out! | beer$$money | investorshub | 01/05/2018 5:53:12 PM |
News, Short Squeeze, Breakout and More Instantly...
HypGen Inc Company Name:
HPGN Stock Symbol:
OTCMKTS Market:
CENTURY CITY, CA , Jan. 05, 2018 (GLOBE NEWSWIRE) -- HypGen Inc. (OTCQB: HPGN), announced it will present during the Biotech Showcase™ 2018, in San Francisco. HypGen is developing the drug RP-323 for the treatment of Parkinson's disease. HypGen’s CEO, Dr. McCoy L. More...